Kymera Therapeutics, Inc. logo KYMR - Kymera Therapeutics, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY 0
BUY 23
HOLD 4
SELL 0
STRONG
SELL 0
| PRICE TARGET: $129.64 DETAILS
HIGH: $155.00
LOW: $97.00
MEDIAN: $135.00
CONSENSUS: $129.64
UPSIDE: 7.83%
AlphaVal

AlphaVal

Deterministic, archetype-aware fair value

AlphaVal Unavailable

AlphaVal: KYMR has had negative net income and negative EPS in all 5 available fiscal year(s). Quality gate: persistently unprofitable companies are excluded.